TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
FORMA Therapeutics, Inc.
US Patent
FORMA Therapeutics, Inc.
US Patent
Affinity DataIC50: 125nMAssay Description:The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
FORMA Therapeutics, Inc.
US Patent
FORMA Therapeutics, Inc.
US Patent
Affinity DataIC50: 125nMAssay Description:The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...More data for this Ligand-Target Pair
TargetUbiquitin carboxyl-terminal hydrolase 1(Homo sapiens (Human))
FORMA Therapeutics, Inc.
US Patent
FORMA Therapeutics, Inc.
US Patent
Affinity DataIC50: 125nMAssay Description:The HTS assay was performed in a final volume of 20 μL in assay buffer containing 20 mM Tris-HCl (pH 8.0, (1M Tris-HCl, pH 8.0 solution; Corning...More data for this Ligand-Target Pair